Internal Medicine, Nephrology · Fargo, ND
NPI
1891802278
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
3000 32nd Ave S
Fargo, ND, 58103
Phone (701) 364-8000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$247K
2,112 prescriptions
Company payments, 2025
$2,912
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey W Skogen prescribed most often to Medicare patients was Allopurinol, with 550 prescriptions and refills. In total Jeffrey W Skogen wrote 2,112 Medicare prescriptions that cost $247K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-12-14.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Allopurinol Generic | 550 | 1,294 | 163 | $12K |
| Furosemide Generic | 150 | 345 | 53 | $1,264 |
| Febuxostat Generic | 122 | 242 | 36 | $12K |
| Metoprolol Succinate Generic | 84 | 176 | 27 | $1,341 |
| Spironolactone Generic | 81 | 182 | 27 | $954 |
| Carvedilol Generic | 61 | 147 | 17 | $873 |
| Losartan Potassium Generic | 61 | 155 | 22 | $1,060 |
| Probenecid Generic | 57 | 104 | 18 | $3,610 |
| Lisinopril Generic | 51 | 131 | 22 | $522 |
| Amlodipine Besylate Generic | 49 | 90 | 14 | $777 |
| Colchicine Generic | 48 | 107 | 23 | $4,104 |
| Tamsulosin Hcl Generic | 48 | 93 | 11 | $738 |
| Torsemide Generic | 46 | 91 | 13 | $781 |
| Atorvastatin Calcium Generic | 44 | 104 | 16 | $422 |
| Omeprazole Generic | 44 | 90 | 12 | $439 |
Brand drugs: 108 claims; generic drugs: 1,993 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey W Skogen $2,912 ($2,912 in general payments such as food, travel and fees) from 2 companies. The largest payer was Amgen Inc. with $2,844.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.